CD81 and nasopharyngeal carcinoma: In fact, CD63+/CD81+/HSP70+ EVs rich with LMP1 from in vitro cultured NPC cells have been shown to confer radio-resistance to recipient NPC cells via activation of P38 MAPK signaling [14].